Glucose-Lowering Effects and Safety of Adding 0.25 or 0.5 mg Duvie
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 159 participants.
Also called NCT03770052
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 159 participants
- Registry
-
NCT03770052
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT03770052. Randomized; double masking; primary purpose treatment. Start 2018-10-24 (actual); primary completion 2021-08-19 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Glucose-Lowering Effects and Safety of Adding 0.25 or 0.5 mg Duvie
- Condition
- Type 2 Diabetes Mellitus
- Condition
- Inadequate Glucose Control
- Intervention (Drug)
- duvie
- Lead sponsor
- Pusan National University Hospital
- Collaborator
- Chong Kun Dang Pharmaceutical Corp.
Record details
- Record id
cardio:ct-nct03770052- Content hash
5a091ef0624a6d41a6cb9be47c51767171e63d25ac9bf5d7e2ea6ea0520cb7d2